Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1800 1
1802 1
1815 1
1828 2
1841 1
1843 1
1844 1
1854 1
1855 2
1858 1
1859 5
1860 2
1864 1
1867 3
1868 2
1869 1
1870 1
1871 3
1872 1
1874 1
1876 1
1877 1
1878 2
1879 3
1880 3
1881 1
1883 2
1884 1
1885 2
1886 2
1887 1
1888 1
1889 1
1890 1
1891 1
1896 2
1897 3
1898 2
1901 2
1902 1
1908 1
1912 2
1914 2
1915 1
1917 1
1918 3
1920 4
1921 2
1922 5
1923 1
1925 2
1926 1
1927 2
1928 3
1930 3
1931 2
1932 3
1933 3
1934 3
1935 2
1936 1
1937 4
1938 4
1939 8
1941 4
1942 5
1943 1
1944 6
1945 4
1946 22
1947 33
1948 29
1949 34
1950 37
1951 31
1952 36
1953 31
1954 17
1955 41
1956 46
1957 42
1958 37
1959 42
1960 42
1961 24
1962 47
1963 60
1964 72
1965 66
1966 85
1967 84
1968 107
1969 93
1970 91
1971 105
1972 117
1973 87
1974 94
1975 135
1976 142
1977 148
1978 145
1979 161
1980 120
1981 148
1982 147
1983 175
1984 201
1985 183
1986 180
1987 185
1988 208
1989 216
1990 248
1991 236
1992 261
1993 243
1994 245
1995 233
1996 270
1997 249
1998 275
1999 249
2000 257
2001 252
2002 314
2003 299
2004 335
2005 375
2006 386
2007 426
2008 477
2009 475
2010 605
2011 569
2012 639
2013 707
2014 782
2015 709
2016 832
2017 726
2018 770
2019 832
2020 942
2021 1007
2022 943
2023 889
2024 187

Text availability

Article attribute

Article type

Publication date

Search Results

19,756 results

Results by year

Filters applied: . Clear all
Page 1
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP. Glaviano A, et al. Among authors: brown jr. Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6. Mol Cancer. 2023. PMID: 37596643 Free PMC article. Review.
Updating the Definition of Cancer.
Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Brown JS, et al. Mol Cancer Res. 2023 Nov 1;21(11):1142-1147. doi: 10.1158/1541-7786.MCR-23-0411. Mol Cancer Res. 2023. PMID: 37409952 Free PMC article.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
Mato AR, Woyach JA, Brown JR, Ghia P, Patel K, Eyre TA, Munir T, Lech-Maranda E, Lamanna N, Tam CS, Shah NN, Coombs CC, Ujjani CS, Fakhri B, Cheah CY, Patel MR, Alencar AJ, Cohen JB, Gerson JN, Flinn IW, Ma S, Jagadeesh D, Rhodes JM, Hernandez-Ilizaliturri F, Zinzani PL, Seymour JF, Balbas M, Nair B, Abada P, Wang C, Ruppert AS, Wang D, Tsai DE, Wierda WG, Jurczak W. Mato AR, et al. Among authors: brown jr. N Engl J Med. 2023 Jul 6;389(1):33-44. doi: 10.1056/NEJMoa2300696. N Engl J Med. 2023. PMID: 37407001 Clinical Trial.
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.
Seymour JF, Byrd JC, Ghia P, Kater AP, Chanan-Khan A, Furman RR, O'Brien S, Brown JR, Munir T, Mato A, Stilgenbauer S, Bajwa N, Miranda P, Higgins K, John E, de Borja M, Jurczak W, Woyach JA. Seymour JF, et al. Among authors: brown jr. Blood. 2023 Aug 24;142(8):687-699. doi: 10.1182/blood.2022018818. Blood. 2023. PMID: 37390310 Free PMC article. Clinical Trial.
BRAG about (s)lots.
Brown JC, Hell JW, Gerges NZ. Brown JC, et al. J Cell Biol. 2023 Dec 4;222(12):e202310023. doi: 10.1083/jcb.202310023. Epub 2023 Nov 8. J Cell Biol. 2023. PMID: 37938213 Free article.
Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM. Grisham RN, et al. Among authors: brown j. Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. Int J Gynecol Cancer. 2023. PMID: 37591609 Free PMC article.
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.
Tsai JM, Aguirre JD, Li YD, Brown J, Focht V, Kater L, Kempf G, Sandoval B, Schmitt S, Rutter JC, Galli P, Sandate CR, Cutler JA, Zou C, Donovan KA, Lumpkin RJ, Cavadini S, Park PMC, Sievers Q, Hatton C, Ener E, Regalado BD, Sperling MT, Słabicki M, Kim J, Zon R, Zhang Z, Miller PG, Belizaire R, Sperling AS, Fischer ES, Irizarry R, Armstrong SA, Thomä NH, Ebert BL. Tsai JM, et al. Among authors: brown j. Mol Cell. 2023 Aug 3;83(15):2753-2767.e10. doi: 10.1016/j.molcel.2023.06.028. Epub 2023 Jul 20. Mol Cell. 2023. PMID: 37478846 Free article.
Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome.
Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. Wang M, et al. Among authors: brown jm. Cell. 2023 Jun 22;186(13):2839-2852.e21. doi: 10.1016/j.cell.2023.05.037. Cell. 2023. PMID: 37352836
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Munir T, Cairns DA, Bloor A, Allsup D, Cwynarski K, Pettitt A, Paneesha S, Fox CP, Eyre TA, Forconi F, Elmusharaf N, Kennedy B, Gribben J, Pemberton N, Sheehy O, Preston G, Schuh A, Walewska R, Duley L, Howard D, Hockaday A, Jackson S, Greatorex N, Girvan S, Bell S, Brown JM, Webster N, Dalal S, de Tute R, Rawstron A, Patten PEM, Hillmen P; National Cancer Research Institute Chronic Lymphocytic Leukemia Subgroup. Munir T, et al. Among authors: brown jm. N Engl J Med. 2024 Jan 25;390(4):326-337. doi: 10.1056/NEJMoa2310063. Epub 2023 Dec 10. N Engl J Med. 2024. PMID: 38078508 Clinical Trial.
Condensate cooperativity underlies transgenerational gene silencing.
Du Z, Shi K, Brown JS, He T, Wu WS, Zhang Y, Lee HC, Zhang D. Du Z, et al. Among authors: brown js. Cell Rep. 2023 Aug 29;42(8):112859. doi: 10.1016/j.celrep.2023.112859. Epub 2023 Jul 27. Cell Rep. 2023. PMID: 37505984 Free PMC article.
19,756 results
You have reached the last available page of results. Please see the User Guide for more information.